Propranolol (1 mg/kg/day) with intralesional bleomycin versus propranolol monotherapy for infantile hemangioma: a randomized controlled trial
In infants with IH, augmenting a low-dose oral propranolol regimen (1 mg/kg/day) with monthly intralesional bleomycin is significantly more effective than low-dose propranolol monotherapy. This combination strategy accelerates tumor regression and yields superior cosmetic outcomes, all while maintaining a comparable safety profile.
Authors
- Bin Zhou (ORCID: https://orcid.org/0000-0001-5779-9085)
- Sailing He (ORCID: https://orcid.org/0000-0002-3401-1125)
- Xinxian Liu
- Yanyan Guo (ORCID: https://orcid.org/0000-0003-4609-6282)
Institutions
- Wuhan Children's Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.3389/fphar.2025.1710517
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 0.00